Peter C Fung

USPTO Granted Patents = 8 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 28(Granted Patents)

Location History:

Newport, NY (US) (2017)
San Mateo, CA (US) (2018 - 2022)

Company Filing History:

4 out of 919

Gilead Sciences, Inc.

Years Active: 2017-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12152037 - Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor (2024-11-26),

2. 12102625 - Solid forms of FXR agonists (2024-10-01),

3. 11524005 - Solid forms of FXR agonists (2022-12-13),

4. 11339168 - Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors (2022-05-24),

5. 10713732 - System and method for implementing unified billing and unified rating operations (2020-07-14),

6. 9892467 - System and method for implementing charge centric billing (2018-02-13),

7. 9862728 - Crystalline forms of an antiviral compound (2018-01-09),

8. 9562058 - Crystalline forms of an antiviral compound (2017-02-07),

Title: The Innovative Contributions of Peter C Fung

Introduction

Peter C Fung is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work primarily focuses on the development of solid forms of various compounds that have therapeutic applications.

Latest Patents

Among his latest patents is the crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine, which serves as a Syk inhibitor. This patent details the solid forms of the compound and provides processes for making these solid forms, along with methods of use. Another significant patent involves novel solid forms of FXR agonists, which includes pharmaceutical compositions and methods for treating conditions mediated by FXR.

Career Highlights

Peter has worked with prominent companies such as Gilead Sciences, Inc. and NetSuite Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Peter has collaborated with talented individuals, including Olga Viktorovna Lapina and Dennis Paul Shak. These collaborations have further enhanced his innovative work and contributions to the field.

Conclusion

Peter C Fung's innovative work and numerous patents reflect his dedication to advancing pharmaceutical science. His contributions continue to impact the industry positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.